SciClone Pharmaceuticals (Holdings) Limited

SHSC:6600 Rapport sur les actions

Capitalisation boursière : HK$11.4b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

SciClone Pharmaceuticals (Holdings) Croissance future

Future contrôle des critères 3/6

SciClone Pharmaceuticals (Holdings) is forecast to grow earnings and revenue by 4.7% and 12.9% per annum respectively. EPS is expected to grow by 1.3% per annum. Return on equity is forecast to be 24.1% in 3 years.

Informations clés

4.7%

Taux de croissance des bénéfices

1.3%

Taux de croissance du BPA

Pharmaceuticals croissance des bénéfices10.8%
Taux de croissance des recettes12.9%
Rendement futur des capitaux propres24.1%
Couverture par les analystes

Low

Dernière mise à jour03 Apr 2024

Mises à jour récentes de la croissance future

Pas de mise à jour

Recent updates

Prévisions de croissance des bénéfices et des revenus

SHSC:6600 - Estimations futures des analystes et données financières antérieures (CNY Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/20254,0861,233N/AN/A1
12/31/20243,6101,150N/A1,0571
12/31/20233,1561,1221,3271,404N/A
9/30/20233,0171,0381,1851,322N/A
6/30/20232,8789531,0431,239N/A
3/31/20232,8149041,0151,211N/A
12/31/20222,7508559871,184N/A
9/30/20222,7068441,1071,214N/A
6/30/20222,6628331,2261,245N/A
3/31/20222,5908781,0321,137N/A
12/31/20212,5189238391,029N/A
9/30/20212,259837506840N/A
6/30/20212,089779358724N/A
3/31/20212,004766435853N/A
12/31/20201,919754512981N/A
9/30/20202,001817657974N/A
12/31/20191,7086159991,032N/A
12/31/20181,409535143167N/A
12/31/20171,21320143154N/A
6/30/20171,166294N/A242N/A
3/31/20171,146258N/A187N/A
12/31/20161,112213N/A240N/A
9/30/20161,060246N/A221N/A
6/30/20161,072257N/A231N/A
3/31/20161,034183N/A214N/A
12/31/20151,021191N/A211N/A
9/30/2015991130N/A200N/A
6/30/2015913102N/A210N/A
3/31/2015879186N/A222N/A
12/31/2014836156N/A171N/A
9/30/2014774133N/A148N/A
6/30/2014790140N/A173N/A
3/31/201477068N/A17N/A
12/31/201376966N/A58N/A
9/30/201378078N/A88N/A
6/30/2013816-56N/A87N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: 6600's forecast earnings growth (4.7% per year) is above the savings rate (2.2%).

Bénéfices vs marché: 6600's earnings (4.7% per year) are forecast to grow slower than the Hong Kong market (11.6% per year).

Croissance élevée des bénéfices: 6600's earnings are forecast to grow, but not significantly.

Chiffre d'affaires vs marché: 6600's revenue (12.9% per year) is forecast to grow faster than the Hong Kong market (7.9% per year).

Croissance élevée des revenus: 6600's revenue (12.9% per year) is forecast to grow slower than 20% per year.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: 6600's Return on Equity is forecast to be high in 3 years time (24.1%)

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y